07:00 , Apr 28, 2014 |  BC Week In Review  |  Financial News

ProNAi completes venture financing

ProNAi Therapeutics Inc. , Kalamazoo, Mich.   Business: Cancer   Date completed: 4/21/14   Type: Venture financing   Raised: $59.5 million   Investors: Vivo Capital; Frazier Healthcare; OrbiMed Advisors; Adams Street Partners; RA Capital Management;...
23:57 , Apr 21, 2014 |  BC Extra  |  Financial News

ProNAi raises $59.5 million D round

ProNAi Therapeutics Inc. (Kalamazoo, Mich.) raised $59.5 million in a series D round led by new investor Vivo Capital. New investors Frazier Healthcare Ventures; OrbiMed Advisors; Adams Street Partners; RA Capital Management; Caxton Alternative Management;...
08:00 , Dec 24, 2007 |  BioCentury  |  Emerging Company Profile

Corporate Profile

ProNAi Therapeutics Inc. Kalamazoo, Mich. Technology: Single-stranded DNA interfering therapeutic agents Disease focus: Cancer Clinical status: Preclinical Founded: 2004 by Robert Forgey, Neal Goodwin, Don Parfet, Mina Sooch and Eli Thomssen University collaborators: Wayne State...
01:33 , Sep 8, 2006 |  BC Extra  |  Financial News

RenaMed raises $40 million

RenaMed (Lincoln, R.I.) raised $40 million in a mezzanine financing led by TVM Capital and Lurie Investments. New investors MDS Capital; Merlin BioMed Group; and TSC BioVenture Capital were joined by existing investors Apjohn Ventures;...
00:31 , Aug 16, 2006 |  BC Extra  |  Top Story

Intranasal raises $39.1 million

Intranasal Therapeutics (Montvale, N.J.) raised $39.1 million in a series A round led by SV Life Sciences. Burrill & Co.; Tullis-Dickerson; Fidelity Biosciences; Apjohn Ventures; Fort Washington Capital; Commonwealth Seed Capital; and Kentucky Co-Investment Partners...
01:06 , Sep 21, 2005 |  BC Extra  |  Financial News

Kereos raises $19.5 million

Kereos (St. Louis, Mo.) raised $19.5 million in a series B round led by new investors Prolog Ventures; Triathlon; Charter Life Sciences; and existing investor RiverVest Venture Partners. Existing investor Barnes-Jewish Hospital and new investors...